Filing Details

Accession Number:
0001610717-24-000411
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-02 17:35:48
Reporting Period:
2024-08-01
Accepted Time:
2024-08-02 17:35:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246842 A Mark Goldsmith C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-01 10,000 $4.09 321,885 No 4 M Direct
Common Stock Disposition 2024-08-01 6,783 $45.60 315,102 No 4 S Direct
Common Stock Disposition 2024-08-01 3,217 $46.48 311,885 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-08-01 10,000 $0.00 10,000 $4.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
281,229 2023-03-13 2029-03-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,424 Indirect Trust
Common Stock 25,424 Indirect Trust
Common Stock 465,604 Indirect Trust
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023.
  2. Includes 210,375 restricted stock units.
  3. This transaction was executed in multiple trades in prices ranging from $45.23 to $46.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. This transaction was executed in multiple trades in prices ranging from $46.23 to $46.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. Held by Jonathan Goldsmith Revocable Trust.
  6. Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
  7. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.